001 | 817964 | ||
005 | 20220930130104.0 | ||
024 | 7 | _ | |a 10.3390/cancers7010287 |2 doi |
024 | 7 | _ | |a 2128/17155 |2 Handle |
024 | 7 | _ | |a pmid:25635760 |2 pmid |
024 | 7 | _ | |a WOS:000209951000010 |2 WOS |
024 | 7 | _ | |a altmetric:3212484 |2 altmetric |
037 | _ | _ | |a FZJ-2016-04543 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Hussein, Amr |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value |
260 | _ | _ | |a Basel |c 2015 |b MDPI |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1548679473_6660 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal NPV. A comparison of different PET data analyses was performed applying individualized standardized uptake values (SUV), PET-derived metabolic tumor volume (MTV) and the product of both parameters, termed total lesion glycolysis (TLG); Methods: One-hundred-eight PET datasets (PET1, n = 54; PET2, n = 54) of 54 children were analysed by visual and semi-quantitative means. SUVmax, SUVmean, MTV and TLG were obtained the results of both PETs and the relative change from PET1 to PET2 (Δ in %) were compared for their capability of identifying responders and non-responders using receiver operating characteristics (ROC)-curves. In consideration of individual variations in noise and contrasts levels all parameters were additionally obtained after threshold correction to lean body mass and background; Results: All semi-quantitative SUV estimates obtained at PET2 were significantly superior to the visual PET2 analysis. However, ΔSUVmax revealed the best results (area under the curve, 0.92; p < 0.001; sensitivity 100%; specificity 85.4%; PPV 46.2%; NPV 100%; accuracy, 87.0%) but was not significantly superior to SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean body mass and background individualization of the datasets did not impove the results of the ROC analyses; Conclusions: Sophisticated semi-quantitative PET measures in early response assessment of pHL patients do not perform significantly better than the previously proposed ΔSUVmax. All analytical strategies failed to improve the impaired PPV to a clinically acceptable level while preserving the excellent NPV. |
536 | _ | _ | |a 573 - Neuroimaging (POF3-573) |0 G:(DE-HGF)POF3-573 |c POF3-573 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Furth, Christian |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Schönberger, Stefan |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Hundsdoerfer, Patrick |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Steffen, Ingo |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Amthauer, Holger |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Müller, Hans-Wilhelm |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Hautzel, Hubertus |0 P:(DE-Juel1)132313 |b 7 |e Corresponding author |
773 | _ | _ | |a 10.3390/cancers7010287 |g Vol. 7, no. 1, p. 287 - 304 |0 PERI:(DE-600)2527080-1 |n 1 |p 287 - 304 |t Cancers |v 7 |y 2015 |x 2072-6694 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.pdf |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.gif?subformat=icon |x icon |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/817964/files/cancers-07-00287.pdf?subformat=pdfa |x pdfa |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:817964 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)132313 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |2 G:(DE-HGF)POF3-500 |v Neuroimaging |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
920 | 1 | _ | |0 I:(DE-Juel1)KME-20110218 |k KME |l KME |x 0 |
920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-Juel1)KME-20110218 |
980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
980 | _ | _ | |a APC |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a APC |
980 | 1 | _ | |a FullTexts |
981 | _ | _ | |a I:(DE-Juel1)IBOC-20090406 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|